Top MarketRank™ StocksTop MarketRank™NYSE:SYK Stryker (SYK) Stock Price, News & Analysis $388.28 +2.65 (+0.69%) Closing price 02/13/2025 03:59 PM EasternExtended Trading$388.38 +0.10 (+0.03%) As of 02/13/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Stryker Stock (NYSE:SYK) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Stryker alerts:Sign Up Key Stats Today's Range$383.44▼$388.8050-Day Range$355.17▼$399.8352-Week Range$314.93▼$406.19Volume916,622 shsAverage Volume1.49 million shsMarket Capitalization$148.02 billionP/E Ratio50.04Dividend Yield0.87%Price Target$420.68Consensus RatingModerate Buy Company OverviewStryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.Read More… Stryker Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks97th Percentile Overall ScoreSYK MarketRank™: Stryker scored higher than 97% of companies evaluated by MarketBeat, and ranked 19th out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.4 / 5Analyst RatingModerate Buy Consensus RatingStryker has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 16 buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageStryker has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Stryker's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth10.16% Earnings GrowthEarnings for Stryker are expected to grow by 10.16% in the coming year, from $13.49 to $14.86 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Stryker is 50.04, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.15.Price to Earnings Ratio vs. SectorThe P/E ratio of Stryker is 50.04, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.08.Price to Earnings Growth RatioStryker has a PEG Ratio of 2.98. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioStryker has a P/B Ratio of 7.17. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Stryker's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.11% of the float of Stryker has been sold short.Short Interest Ratio / Days to CoverStryker has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Stryker has recently decreased by 15.60%, indicating that investor sentiment is improving significantly. Dividend3.3 / 5Dividend StrengthStrong Dividend YieldStryker has a dividend yield of 0.85%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthStryker has been increasing its dividend for 15 years.Dividend CoverageThe dividend payout ratio of Stryker is 43.30%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Stryker will have a dividend payout ratio of 22.61% next year. This indicates that Stryker will be able to sustain or increase its dividend.Read more about Stryker's dividend. Sustainability and ESG4.2 / 5Environmental Score-0.95 Percentage of Shares Shorted1.11% of the float of Stryker has been sold short.Short Interest Ratio / Days to CoverStryker has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Stryker has recently decreased by 15.60%, indicating that investor sentiment is improving significantly. News and Social Media4.0 / 5News Sentiment1.20 News SentimentStryker has a news sentiment score of 1.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 47 news articles for Stryker this week, compared to 17 articles on an average week.Search Interest39 people have searched for SYK on MarketBeat in the last 30 days. This is an increase of 160% compared to the previous 30 days.MarketBeat Follows21 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is an increase of 17% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Stryker insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $78,993,998.00 in company stock.Percentage Held by InsidersOnly 5.90% of the stock of Stryker is held by insiders.Percentage Held by Institutions77.09% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Stryker's insider trading history. Receive SYK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter. Email Address SYK Stock News HeadlinesInsider Selling: Stryker Co. (NYSE:SYK) Director Sells 201,392 Shares of StockFebruary 4, 2025 | insidertrades.comStryker to participate in Citi’s 2025 Unplugged Medtech and Life Sciences Access DayFebruary 13 at 10:07 PM | markets.businessinsider.comElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.February 14, 2025 | True Market Insiders (Ad)GREENLEAF TRUST Reduces Stake in Stryker Corp: A Strategic Portfolio AdjustmentFebruary 13 at 5:25 PM | gurufocus.comStryker Corp (SYK) to Present at Citi's 2025 Unplugged Medtech and Life Sciences Access DayFebruary 13 at 8:30 AM | gurufocus.comStryker to participate in Citi's 2025 Unplugged Medtech and Life Sciences Access DayFebruary 13 at 8:00 AM | globenewswire.comDecoding Stryker Corp (SYK): A Strategic SWOT InsightFebruary 13 at 12:33 AM | gurufocus.comWhy Stryker Corporation (SYK) is the Best Medical Device Stock to BuyFebruary 12 at 6:34 PM | msn.comSee More Headlines SYK Stock Analysis - Frequently Asked Questions How have SYK shares performed this year? Stryker's stock was trading at $360.05 at the beginning of the year. Since then, SYK stock has increased by 7.8% and is now trading at $388.2820. View the best growth stocks for 2025 here. How were Stryker's earnings last quarter? Stryker Co. (NYSE:SYK) released its earnings results on Tuesday, January, 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a net margin of 13.25% and a trailing twelve-month return on equity of 23.58%. Read the conference call transcript. Does Stryker have any subsidiaries? Stryker subsidiaries include these companies: Vocera Communications, Vocera, Gauss Surgical, OrthoSensor, Wright Medical Group, Cardan Robotics, Mobius Imaging, and more. Who are Stryker's major shareholders? Top institutional shareholders of Stryker include Vanguard Group Inc. (8.58%), Greenleaf Trust (4.65%), Wellington Management Group LLP (2.20%) and FMR LLC (2.11%). Insiders that own company stock include Ronda E Stryker, Kevin Lobo, James Andrew Pierce, Allan C Golston, M Kathryn Fink, Viju Menon, Robert S Fletcher, Srikant M Datar, William E Berry Jr and Glenn S Boehnlein. View institutional ownership trends. How do I buy shares of Stryker? Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Stryker own? Based on aggregate information from My MarketBeat watchlists, some other companies that Stryker investors own include Broadcom (AVGO), ServiceNow (NOW), BlackRock (BLK), NVIDIA (NVDA), Meta Platforms (META), UnitedHealth Group (UNH) and Advanced Micro Devices (AMD). Company Calendar Ex-Dividend for 1/31 Dividend12/31/2024Last Earnings1/28/2025Dividend Payable1/31/2025Today2/14/2025Next Earnings (Estimated)4/29/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:SYK CUSIP86366710 CIK310764 Webwww.strykercorp.com Phone(269) 385-2600Fax269-385-1062Employees52,000Year Founded1941Price Target and Rating Average Stock Price Target$420.68 High Stock Price Target$450.00 Low Stock Price Target$370.00 Potential Upside/Downside+8.3%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage20 Analysts Profitability EPS (Most Recent Fiscal Year)$7.76 Trailing P/E Ratio50.04 Forward P/E Ratio28.78 P/E Growth2.98Net Income$2.99 billion Net Margins13.25% Pretax Margin15.45% Return on Equity23.58% Return on Assets11.37% Debt Debt-to-Equity Ratio0.59 Current Ratio1.95 Quick Ratio1.32 Sales & Book Value Annual Sales$22.60 billion Price / Sales6.55 Cash Flow$14.79 per share Price / Cash Flow26.26 Book Value$54.13 per share Price / Book7.17Miscellaneous Outstanding Shares381,220,000Free Float358,724,000Market Cap$148.02 billion OptionableOptionable Beta0.96 Social Links Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (NYSE:SYK) was last updated on 2/14/2025 by MarketBeat.com Staff From Our Partners*Breaking News!* This Pharma NASDAQ Company and the U.S Army!!! This Little Known NASDAQ Company just released positive results from its drugs that have been undergoing testi...Trading Wire | Sponsored[RFK Jr CONFIRMED] But Will THIS Be His DownfallRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s #1 investment during Trump’s termWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump Policies Are Going to Light a Fire Under GoldHow You Can Profit from Trump's Bold Moves in 2025 Donald Trump’s bold policies are creating unprecedented ...Golden Portfolio | SponsoredElon has entered the MarkBeat conversationSpivey's firm accurately warned of both the 2008 and 2020 stock market crashes and have charged institutional ...Altimetry | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredJUST RELEASED: HUGE NEW A.I. TRADEI’ve traded every major tech boom since the dawn of the personal computer. And I can tell you one thing wit...The Oxford Club | SponsoredFrom bankrupt to delivering 610,000% returnsWalk the empty streets of this barren town and you would have no idea that behind the sand-scarred blight is o...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stryker Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stryker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.